Pharmaceuticals: Major
Argentine companies operating in the same pharmaceuticals: major industry
The list below has Argentine companies that operate under the same industry, pharmaceuticals: major. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 or those with the best price dynamics like BIOGEN INC CEDEAR EAC 13 RE 1 COM(USD), thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 877.54 T ARS | 15.950 USD | +0.95% | 336 | 0.63 | 84.80 | 193.92 ARS | +391.73% | 0.28% | Health technology | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 877.54 T ARS | 19,050.000 ARS | +0.79% | 4.37 K | 0.75 | 98.24 | 193.92 ARS | +527.09% | 0.28% | Health technology | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 413.94 T ARS | 10.700 USD | −0.47% | 1.51 K | 1.99 | 31.30 | 352.44 ARS | +130.17% | 1.47% | Health technology | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 413.94 T ARS | 1,300.000 ARS | 0.00% | 38 | 1.05 | — | — | — | — | Health technology | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 413.94 T ARS | 13,275.000 ARS | +2.51% | 14.25 K | 0.35 | 37.67 | 352.44 ARS | +193.52% | 1.47% | Health technology | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 377.91 T ARS | 20.450 USD | +2.25% | 82 | 1.62 | 9.92 | 2,124.76 ARS | +107.54% | 1.58% | Health technology | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 377.91 T ARS | 24,750.000 ARS | +1.54% | 1.31 K | 1.65 | 11.65 | 2,124.76 ARS | +164.67% | 1.58% | Health technology | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 243.6 T ARS | 37.150 USD | 0.00% | 4 | 0.01 | 46.94 | 815.85 ARS | +207.61% | 1.27% | Health technology | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 243.6 T ARS | 45,175.000 ARS | −0.11% | 778 | 1.27 | 55.37 | 815.85 ARS | +292.28% | 1.27% | Health technology | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 239.83 T ARS | 18.950 USD | +4.12% | 236 | 2.21 | 16.00 | 1,220.67 ARS | +12,566.98% | 1.72% | Health technology | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 239.83 T ARS | 21,700.000 ARS | +1.88% | 9.66 K | 1.36 | 17.78 | 1,220.67 ARS | +16,053.66% | 1.72% | Health technology | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 229.31 T ARS | 27.200 USD | +4.82% | 1 | 0.32 | 4.77 | 5,874.32 ARS | −24.89% | 3.36% | Health technology | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 229.31 T ARS | 33,300.000 ARS | +2.07% | 207 | 1.19 | 5.67 | 5,874.32 ARS | −4.22% | 3.36% | Health technology | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 157.88 T ARS | 6.650 USD | +1.68% | 1.35 K | 1.27 | 21.59 | 317.52 ARS | — | 3.37% | Health technology | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 157.88 T ARS | 8,020.000 ARS | +2.04% | 58.12 K | 3.60 | 25.26 | 317.52 ARS | — | 3.37% | Health technology | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 120.02 T ARS | 22,700.000 ARS | +1.23% | 1.14 K | 2.03 | — | −1,193.64 ARS | −422.98% | 2.52% | Health technology | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 78.27 T ARS | 9.240 USD | +0.22% | 60 | 1.20 | 27.31 | 348.78 ARS | +40.76% | 2.83% | Health technology | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 78.27 T ARS | 11,175.000 ARS | −0.67% | 168 | 0.22 | 32.04 | 348.78 ARS | +79.50% | 2.83% | Health technology | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21.81 T ARS | 11.050 USD | +5.24% | 47 | 3.07 | 14.64 | 778.26 ARS | +284.16% | 0.00% | Health technology | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21.81 T ARS | 13,125.000 ARS | +2.54% | 4.93 K | 3.51 | 16.86 | 778.26 ARS | +389.90% | 0.00% | Health technology | — |
 RICHLABORATORIOS RICHMOND SACIF | 124.36 B ARS | 1,540.000 ARS | −3.14% | 13.43 K | 3.20 | 15.99 | 96.29 ARS | — | 0.00% | Health technology | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5.11 B ARS | 120.000 ARS | 0.00% | 412 | 0.37 | 28.11 | 4.27 ARS | +64.50% | 0.00% | Health technology | — |